Bruker “announced that it has acquired Spectral Instruments Imaging LLC, a leader in preclinical in-vivo optical imaging systems. This acquisition fills a gap in the technology and product portfolio of the Bruker BioSpin Preclinical Imaging division, broadening its range of preclinical solutions for disease research. Established in 2009 in Tucson, Spectral Instruments Imaging (SII) is at the forefront of technology for co-registered bioluminescence, fluorescence, and X-ray preclinical imaging. SII systems are engineered with advanced optics, patented illumination, -90o C air-cooled high sensitivity cameras, absolute calibration for quantifiable imaging, excellent flexibility and ease of use.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BRKR:
- BRKR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Bruker Corp Establishes New Financial Obligation
- Bruker Corp Signs Major Agreement with Investors
- Bruker announces agreement to acquire Chemspeed, no terms
- Bruker sees ‘solid’ organic revenue growth, adjusted EPS growth for FY24
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue